Annual Net Income:
-$72.70M+$62.65M(+46.29%)Summary
- As of today, GLUE annual net profit is -$72.70 million, with the most recent change of +$62.65 million (+46.29%) on December 31, 2024.
- During the last 3 years, GLUE annual net income has risen by +$1.26 million (+1.70%).
- GLUE annual net income is now -839.28% below its all-time high of -$7.74 million, reached on December 31, 2019.
Performance
GLUE Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
-$27.08M-$14.79M(-120.26%)Summary
- As of today, GLUE quarterly net profit is -$27.08 million, with the most recent change of -$14.79 million (-120.26%) on September 30, 2025.
- Over the past year, GLUE quarterly net income has dropped by -$3.22 million (-13.50%).
- GLUE quarterly net income is now -157.76% below its all-time high of $46.88 million, reached on March 31, 2025.
Performance
GLUE Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
$20.95M-$3.22M(-13.33%)Summary
- As of today, GLUE TTM net profit is $20.95 million, with the most recent change of -$3.22 million (-13.33%) on September 30, 2025.
- Over the past year, GLUE TTM net income has increased by +$140.34 million (+117.54%).
- GLUE TTM net income is now -13.33% below its all-time high of $24.17 million, reached on June 30, 2025.
Performance
GLUE TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
GLUE Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +46.3% | -13.5% | +117.5% |
| 3Y3 Years | +1.7% | +0.9% | +120.7% |
| 5Y5 Years | -839.3% | -312.9% | +229.1% |
GLUE Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +46.3% | -157.8% | +23.0% | -13.3% | +115.5% |
| 5Y | 5-Year | -839.3% | +46.3% | -157.8% | +23.0% | -13.3% | +115.5% |
| All-Time | All-Time | -839.3% | +46.3% | -157.8% | +23.0% | -13.3% | +115.5% |
GLUE Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$27.08M(-120.3%) | $20.95M(-13.3%) |
| Jun 2025 | - | -$12.29M(-126.2%) | $24.17M(+292.8%) |
| Mar 2025 | - | $46.88M(+248.9%) | $6.15M(+108.5%) |
| Dec 2024 | -$72.70M(+46.3%) | $13.44M(+156.3%) | -$72.70M(+39.1%) |
| Sep 2024 | - | -$23.86M(+21.3%) | -$119.39M(+8.5%) |
| Jun 2024 | - | -$30.31M(+5.2%) | -$130.41M(+3.6%) |
| Mar 2024 | - | -$31.97M(+3.9%) | -$135.28M(+0.1%) |
| Dec 2023 | -$135.35M(-24.7%) | -$33.25M(+4.7%) | -$135.35M(-1.9%) |
| Sep 2023 | - | -$34.88M(+0.8%) | -$132.88M(-6.0%) |
| Jun 2023 | - | -$35.18M(-9.8%) | -$125.32M(-7.5%) |
| Mar 2023 | - | -$32.04M(-4.1%) | -$116.61M(-7.5%) |
| Dec 2022 | -$108.50M | -$30.78M(-12.7%) | -$108.50M(-7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$27.32M(-3.2%) | -$101.16M(-8.0%) |
| Jun 2022 | - | -$26.47M(-10.6%) | -$93.68M(-9.4%) |
| Mar 2022 | - | -$23.93M(-2.1%) | -$85.61M(-15.8%) |
| Dec 2021 | -$73.96M(-106.1%) | -$23.44M(-18.2%) | -$73.96M(-46.4%) |
| Sep 2021 | - | -$19.84M(-7.8%) | -$50.52M(-35.7%) |
| Jun 2021 | - | -$18.41M(-49.9%) | -$37.24M(-53.9%) |
| Mar 2021 | - | -$12.28M(-87.2%) | -$24.20M(-49.1%) |
| Dec 2020 | -$35.88M(-363.6%) | - | - |
| Sep 2020 | - | -$6.56M(-22.3%) | -$16.22M(-67.8%) |
| Jun 2020 | - | -$5.36M(-24.7%) | -$9.67M(-124.7%) |
| Mar 2020 | - | -$4.30M | -$4.30M |
| Dec 2019 | -$7.74M | - | - |
FAQ
- What is Monte Rosa Therapeutics, Inc. annual net profit?
- What is the all-time high annual net income for Monte Rosa Therapeutics, Inc.?
- What is Monte Rosa Therapeutics, Inc. annual net income year-on-year change?
- What is Monte Rosa Therapeutics, Inc. quarterly net profit?
- What is the all-time high quarterly net income for Monte Rosa Therapeutics, Inc.?
- What is Monte Rosa Therapeutics, Inc. quarterly net income year-on-year change?
- What is Monte Rosa Therapeutics, Inc. TTM net profit?
- What is the all-time high TTM net income for Monte Rosa Therapeutics, Inc.?
- What is Monte Rosa Therapeutics, Inc. TTM net income year-on-year change?
What is Monte Rosa Therapeutics, Inc. annual net profit?
The current annual net income of GLUE is -$72.70M
What is the all-time high annual net income for Monte Rosa Therapeutics, Inc.?
Monte Rosa Therapeutics, Inc. all-time high annual net profit is -$7.74M
What is Monte Rosa Therapeutics, Inc. annual net income year-on-year change?
Over the past year, GLUE annual net profit has changed by +$62.65M (+46.29%)
What is Monte Rosa Therapeutics, Inc. quarterly net profit?
The current quarterly net income of GLUE is -$27.08M
What is the all-time high quarterly net income for Monte Rosa Therapeutics, Inc.?
Monte Rosa Therapeutics, Inc. all-time high quarterly net profit is $46.88M
What is Monte Rosa Therapeutics, Inc. quarterly net income year-on-year change?
Over the past year, GLUE quarterly net profit has changed by -$3.22M (-13.50%)
What is Monte Rosa Therapeutics, Inc. TTM net profit?
The current TTM net income of GLUE is $20.95M
What is the all-time high TTM net income for Monte Rosa Therapeutics, Inc.?
Monte Rosa Therapeutics, Inc. all-time high TTM net profit is $24.17M
What is Monte Rosa Therapeutics, Inc. TTM net income year-on-year change?
Over the past year, GLUE TTM net profit has changed by +$140.34M (+117.54%)